Valuation: CVRx, Inc.

Market Cap 6.93Cr 6Cr 5.62Cr 5.13Cr 9.64Cr 660.99Cr 9.81Cr 66Cr 26Cr 330.64Cr 26Cr 25Cr 1.1TCr P/E 2026 *
-1.29x
P/E 2027 * -1.36x
Enterprise Value 7.98Cr 6.91Cr 6.47Cr 5.9Cr 11Cr 761.22Cr 11Cr 76Cr 30Cr 380.78Cr 30Cr 29Cr 1.27TCr EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.7x
Free-Float
85.87%
Yield 2026 *
-
Yield 2027 * -
1 day-1.73%
1 week-52.73%
Current month-49.76%
1 month-52.12%
3 months-61.93%
6 months-61.14%
Current year-63.38%
1 week 2.2
Extreme 2.2
6
1 month 2.2
Extreme 2.2
6
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap.
27/02/26 Free

Chief Executive Officer

4,04,763 1.5443%
27/02/26 Free

Chief Operating Officer

38,000 0.1450%
27/02/26 Free

Executive/Senior Manager

90,964 0.3471%
Change 5-day change 1-year change 3-year change Capi.($)
+9.70%-52.73%-64.09%-85.12% 6.31Cr
+0.09%+1.01%+35.67%+31.36% 1.28TCr
-0.08%-0.29%+20.86%+23.29% 686.61Cr
+5.64%+9.50%+59.16%+38.76% 650.66Cr
+1.44%+3.56% - - 547.64Cr
+3.20%-1.39%-24.46%+44.12% 441.37Cr
-2.54%-4.65%-23.85%-19.51% 407.6Cr
+2.02%+15.27%+58.67%-42.48% 201.57Cr
-6.72%-10.87%-21.59%+171.04% 173.19Cr
+0.92%+6.50%+68.55%-10.15% 171.16Cr
Average +0.22%+753.53%+12.10%+16.81% 457.01Cr
Weighted average by Cap. +0.94%+777.41%+24.24%+27.79%

Financials

2026 *2027 *
Net sales 5.89Cr 5.1Cr 4.77Cr 4.36Cr 8.19Cr 561.61Cr 8.33Cr 56Cr 22Cr 280.93Cr 22Cr 22Cr 937.39Cr 6.62Cr 5.73Cr 5.37Cr 4.9Cr 9.21Cr 631.52Cr 9.37Cr 63Cr 25Cr 315.9Cr 25Cr 24Cr 1.05TCr
Net income -5.35Cr -4.63Cr -4.33Cr -3.96Cr -7.44Cr -510.06Cr -7.57Cr -51Cr -20Cr -255.14Cr -20Cr -20Cr -851.36Cr -5.21Cr -4.52Cr -4.23Cr -3.86Cr -7.26Cr -497.5Cr -7.38Cr -50Cr -19Cr -248.86Cr -20Cr -19Cr -830.39Cr
Net Debt 1.05Cr 91L 85.18L 77.75L 1.46Cr 100.23Cr 1.49Cr 10Cr 3.91Cr 50Cr 3.94Cr 3.86Cr 167.29Cr 4.29Cr 3.72Cr 3.48Cr 3.18Cr 5.98Cr 409.74Cr 6.08Cr 41Cr 16Cr 204.96Cr 16Cr 16Cr 683.9Cr
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
11/26/11 $2.600 +9.70% 25,72,364
10/26/10 $2.370 -0.84% 27,79,819
07/26/07 $2.390 -59.76% 1,47,73,453
06/26/06 $5.940 +6.45% 5,91,250
05/26/05 $5.580 +1.64% 1,74,994
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.370USD
Average target price
5.917USD
Spread / Average Target
+149.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock